EUVIMEDEUVIMED entdecken
Crossref

The Risk of Fragile X Premutation Expansion Is Lower in Carriers Detected by General Prenatal Screening Than in Carriers from Known Fragile X Families

E Geva, Y Yaron, R Shomrat, A Ben-Yehuda, S Zabari, H Peretz, T Naiman, H Yeger, A Orr-Urtreger

Genetic Testing · 2000-09 · 4 (3) · 289-292

DOI: 10.1089/10906570050501524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetic Testing, 2000-09. Verfasst von E Geva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Tel Aviv Sourasky Medical Center, Israel. Hauptthemen laut MEDLINE: Genetic Carrier Screening, Genetic Testing, Mutation, RNA-Binding Proteins. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Fragile X syndrome is the most common cause of inherited mental retardation. For a female premutation carrier, the risk of having a child with a full mutation is positively correlated with the size of the premutation. The current study was performed to evaluate the risk of premutation expansion in the offspring of average-risk carriers detected by general prenatal screening. Over a 4-year period, 9,660 women underwent DNA screening for FMR1 mutation/premutation at the Tel Aviv Sourasky Medical Center. A premutation was defined as a CGG repeat number >50 in the 5' untranslated region (UTR) of exon 1 in the FMR1 gene. The study included only individuals with no family history of X-linked mental retardation or known FMR1 mutations. A premutation was found in 85 women (1 in 114), 68 of whom consented to have prenatal diagnoses in 74 pregnancies. The abnormal allele was transmitted to the offspring in 44 pregnancies. Of these, no change in allele size was noted in 35 pregnancies (79.6%), and expansion within premutation range was evident in 4 pregnancies (9%). In 5 pregnancies (11.4%), expansion to the full mutation was noted. This occurred only in carriers having more than 90 repeats. We conclude that the likelihood of Fragile X premutation expansion to full mutation is significantly lower in individuals ascertained by general prenatal carrier testing than in those from known Fragile X families.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Carrier ScreeningGenetic TestingMutationRNA-Binding ProteinsFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeHumansNerve Tissue ProteinsPregnancyPrenatal DiagnosisRisk AssessmentTrinucleotide Repeats

Substanzen

Fragile X Messenger Ribonucleoprotein 1Nerve Tissue ProteinsRNA-Binding ProteinsFMR1 protein, human

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Tel Aviv Sourasky Medical Center, Israel.

Zitieren

APA

Geva, E., Yaron, Y., Shomrat, R., Ben-Yehuda, A., Zabari, S., Peretz, H., Naiman, T., Yeger, H., & Orr-Urtreger, A. (2000). The Risk of Fragile X Premutation Expansion Is Lower in Carriers Detected by General Prenatal Screening Than in Carriers from Known Fragile X Families. Genetic Testing, 4(3), 289-292. https://doi.org/10.1089/10906570050501524

Vancouver

Geva E, Yaron Y, Shomrat R, Ben-Yehuda A, Zabari S, Peretz H, et al. The Risk of Fragile X Premutation Expansion Is Lower in Carriers Detected by General Prenatal Screening Than in Carriers from Known Fragile X Families. Genetic Testing. 2000;4(3):289-292. doi:10.1089/10906570050501524

BibTeX
@article{Geva2000,
  author = {Geva, E and Yaron, Y and Shomrat, R and Ben-Yehuda, A and Zabari, S and Peretz, H and Naiman, T and Yeger, H and Orr-Urtreger, A},
  title = {The Risk of Fragile X Premutation Expansion Is Lower in Carriers Detected by General Prenatal Screening Than in Carriers from Known Fragile X Families},
  journal = {Genetic Testing},
  year = {2000},
  volume = {4},
  number = {3},
  pages = {289--292},
  doi = {10.1089/10906570050501524}
}
Kostenlos starten →